Abstract
Background and Objectives
Intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (HCC) includes intrahepatic metastasis (IM) and multicenter occurrence (MO). The risk factors for these two types of intrahepatic recurrence have not been well defined.
Methods
The type of intrahepatic recurrence was determined based on histopathological features of 93 HCC patients who underwent a repeat hepatectomy for recurrent HCC. Various clinical and pathological factors were analyzed to define distinct risk factors for different types of intrahepatic recurrence.
Results
The recurrence rates at 1, 2, 3, 5, and 8 years postoperatively were 22.4, 42.9, 61.2, 85.7, and 100 %, respectively, in patients with IM and 5.0, 25.0, 45.5, 67.5, and 100 %, respectively, in patients with MO (p = 0.005). A total of 16 clinical and pathological factors were tested in univariable and multivariable analyses. We found that large-size tumor (>5 cm), multiple tumors (two or more), and vascular invasion were significantly associated with IM recurrence, and liver cirrhosis and Ishak hepatic inflammatory activity were highly associated with MO recurrence. In addition, blood transfusion and a high hepatitis B virus (HBV)-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.
Conclusions
IM and MO recurrences were associated with distinct risk factors, while blood transfusion and high HBV-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.
Similar content being viewed by others
References
Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J SurgOncol 2004, 85:36–41.
Chen PJ, Chen DS, Lai MY, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology. 1989;96:527–9.
Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, Shirabe K, Nishizaki K, Sugimachi K. Prognosis of recurrent hepatocellularcarcinoma: a 10-year surgical experience in Japan, Gastroenterology 1996;111:720–726.
Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Tkayama T, Kawasaki S. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–7.
Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Sakamoto M, Hirohashi S: Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer 1995;75:444–450.
Saeki R, Nagai H, Kaneko S, Unoura M, Yamanaka N, Okamoto E, Kobayashi K, Matsubara K: Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol 2000;33:99–105.
Friemel J, Rechsteiner M, Frick L, Böhm F, Struckmann K, Egger M, Moch H, Heikenwalder M, Weber A: Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer Res 2015;21:1951–1961.
Li Q, Wang J,. Juzi JT, Sun Y, Zheng H, Cui YL, Li HX, Hao XS. Clonality Analysis for Multicentric Origin and Intrahepatic Metastasis in Recurrent and Primary Hepatocellular Carcinoma. J Gastrointest Surg 2008;12:1540–1547.
Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7: 462–503.
Greene FL, Page DL, Fleming ID, et al. (6th eds.). “In AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual.” New York: Springer: New York, 2002.
Arii S, Monden K, Niwano M, Furutani M, Mori A, Mizumoto M, Imamura M. Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg.1998;5:86–92.
Matsuda M, Fujii H, Kono H, Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg. 2001;8:353–9.
Feo F, Pascale RM. Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?. Ann Transl Med 2015;3(1):4–8.
Portolani N, Coniglio A, Ghidoni S, Giovanelli M, BenettiA, Tiberio GA, Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229–35.
Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. Liver resection for transplantable hepatocellularcarcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009;250:738–746.
Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373–382
Poon RT, Fan ST, Wong J. Risk factors, prevention, management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000, 232:10–24.
Cucchetti A, Piscaglia F, Caturelli E, Benvegnu L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann SurgOncol. 2009;16:413–22
Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H, Zhou H, Hao X. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. Surgical Oncology 2009;18:25–30.
Makino Y, Yamanoi A, Kimoto T, Nazmy El-Assal O, Kohno H, Nagasue N. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterology 2000;95:1294–1300.
van Gulik TM, de Graaf W, Dinant S, Busch OR, Gouma DJ. Vascular Occlusion Techniques during Liver Resection. Dig Surg 2007; 24:274–281.
Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115(3):303–9.
Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. 1998; Vox Sang 74Suppl 2 315–319.
Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE. Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 2007; 31: 2044–2051.
Goubran H, Sabry W, Kotb R, Seghatchian J, Burnouf T. Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci 2015;53(2):168–172.
Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21(6):327–348.
Di Bisceglie AM. Hepatitis B and Hepatocellular Carcinoma.Hepatology2009, 49(5): S56-S60.
Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.
Muroyama R, Kato N, Yoshida H, Otsuka M, Moriyama M, Wang Y. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J Hepatol 2006;45:805–812.
Yu SJ, Kim YJ. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. World J Gastroenterol 2014; 20(34): 12039–12044.
Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology1990; 12: 59–65.
Sze KM, Chu GK, Lee JM, Ng OL. C-Terminal Truncated Hepatitis B Virus X Protein Is Associated With Metastasis and Enhances Invasiveness by C-Jun/Matrix Metalloproteinase Protein 10 Activation in Hepatocellular Carcinoma. Hepatology 2013;57:131–139.
Acknowledgments
We thank Dr. Sheng Wei, at the School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, for his assistance in the statistical analysis of this manuscript.
Author Contributions
Shenghua Hao designed, drafted, and revised the study critically for important intellectual content; Ping Fan acquired the data and drafted the study; Shaofei Chen analyzed the data and drafted the study; Caixue Tu interpreted the data and drafted the study; and Chidan Wan analyzed and revised the study critically for important intellectual content. All of the authors have approved the final version for publication and agreed to be accountable for all aspects of the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the review committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Hao, S., Fan, P., Chen, S. et al. Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma. J Gastrointest Surg 21, 312–320 (2017). https://doi.org/10.1007/s11605-016-3311-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-016-3311-z